Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Insmed Inc shares valued at $1,654,338 were purchased by ALFRED ALTOMARI on Aug 13 ’25. At $121.64 per share, ALFRED ALTOMARI acquired 13,600 shares.
Also, SHAROKY MELVIN MD purchased 10,000 shares, netting a total of over 1,215,350 in proceeds.
Before that, Lewis William had sold 6,830 shares from its account. In a trade valued at $750,008, the Chair and CEO traded Insmed Inc shares for $109.81 each. Upon closing the transaction, the insider’s holdings decreased to 6,830 shares, worth approximately $28.74 million.
As published in a research note from Morgan Stanley on August 13, 2025, Insmed Inc [INSM] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $126. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of February 25, 2025, RBC Capital Mkts has initiated its “an Outperform” rating for INSM. Earlier on April 23, 2024, Truist initiated its rating. Their recommendation was “a Buy” for INSM stock.
Analyzing INSM Stock Performance
On last trading session, Insmed Inc [NASDAQ: INSM] rose 0.71% to $122.87. The stock’s lowest price that day was $119.8, but it reached a high of $123.42 in the same session. During the last five days, there has been a surge of approximately 10.44%. Over the course of the year, Insmed Inc shares have jumped approximately 66.09%. Shares of the company reached a 52-week high of $123.42 on 08/13/25 and a 52-week low of $60.40 on 04/09/25.
Support And Resistance Levels for Insmed Inc (INSM)
According to the 24-hour chart, there is a support level at 120.64, which, if violated, would cause prices to drop to 118.41. In the upper region, resistance lies at 124.26. The next price resistance is at 125.65. RSI (Relative Strength Index) is 82.03 on the 14-day chart, showing overbought technical sentiment.
Is Insmed Inc subject to short interest?
Stocks of Insmed Inc saw a sharp steep in short interest on 2025-07-31 dropping by -0.26 million shares to 9.54 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 9.8 million shares. A decline of -2.72% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.67 of the overall float, the days-to-cover ratio (short ratio) decline to 3.67.
Which companies own the most shares of Insmed Inc (INSM)?
In terms of Insmed Inc share price expectations, FactSet research, analysts set an average price target of 125 in the next 12 months, up nearly 2.46% from the previous closing price of $122.0. Analysts anticipate Insmed Inc stock to reach 140 by 2025, with the lowest price target being 110. In spite of this, 14 analysts ranked Insmed Inc stock as Buy at the end of 2025. On February 15, 2024, Wolfe Research assigned a price target of “an Outperform” to the stock and initiated coverage with a $42.
